These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7336983)

  • 1. Central neurotropic activity of homovanillic acid.
    Kleinrok Z; Zarkowski AM
    Acta Physiol Pol; 1981; 32(5):477-85. PubMed ID: 7336983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological analysis of the effect of homovanillic acid on rat behavior].
    Zharkovskiĭ AM; Klejnrok Z
    Farmakol Toksikol; 1981; 44(4):400-3. PubMed ID: 7286195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central action of adrenaline.
    Jagiełło-Wójtowicz E
    Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Homovanilic acid accumulation in the brain of rats as a possible cause of the inhibitory action of psychotropic substances on behavior and motor activity].
    Zharkovskiĭ AM; Allikmets LKh
    Farmakol Toksikol; 1979; 42(5):467-70. PubMed ID: 39774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary investigation on the central action of prostacyclin (PGI2) in rats.
    Rajtar G; Kolasa K; Kleinrok Z
    Pol J Pharmacol Pharm; 1981; 33(6):627-32. PubMed ID: 6752913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of phenoxybenzamine administered intraventricularly in rats.
    Zebrowska-Lupina I
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):223-31. PubMed ID: 945052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of prostaglandins in the action of kinins on the central dopaminergic system in the rat. I. The action of kinins on the central dopaminergic system after pretreatment with indomethacin.
    Kościelak M; Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1980; 32(3):343-56. PubMed ID: 6912578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic studies of the central action of zopiclone: effects on locomotor activity and brain monoamines in rats.
    Liu HJ; Sato K; Shih HC; Shibuya T; Kawamoto H; Kitagawa H
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):121-8. PubMed ID: 2581904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central effects of endogenous and exogenous GABA.
    Czajka R
    Acta Physiol Pol; 1978; 29(3):193-205. PubMed ID: 707139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
    Kozyrska C; Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central action of 6-hydroxytryptamine in rats.
    Jamrozik-Kruk Z; Brus R
    Acta Physiol Pol; 1980; 31(3):253-60. PubMed ID: 6160727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine.
    Kilts CD; Knight DL; Mailman RB; Widerlöv E; Breese GR
    J Pharmacol Exp Ther; 1984 Nov; 231(2):334-42. PubMed ID: 6491985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
    Zebrowska-Lupina I; Malec D; Kleinrok Z
    Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of the homovanillic acid content in the rat brain after the administration of a neuroleptic and the degree of dopamine receptor sensitivity to an agonist].
    Zharkovskiĭ AM; Allikmets LKh; Otter MIa
    Biull Eksp Biol Med; 1979 Jun; 87(6):559-60. PubMed ID: 572714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant activities of WEB 1881, a new nootropic agent.
    Maj J; Rogóz Z; Skuza G; Sowińska H; Nowak G
    Pol J Pharmacol Pharm; 1989; 41(5):439-52. PubMed ID: 2561889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central effects of octopamine administered into the lateral ventricle of rats.
    Kleinrok Z; Jagiełło-Wójtowicz E; Szkilnik E
    Acta Physiol Pol; 1979; 30(4):445-53. PubMed ID: 228526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central action of intraventricularly-injected midodrine in rats.
    Kleinrok Z; Jagiełło-Wójtowicz E; Oktaba-Polkowska A
    Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):217-33. PubMed ID: 6160823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.
    Kõks S; Volke V; Veraksits A; Rünkorg K; Sillat T; Abramov U; Bourin M; Huotari M; Männistö PT; Matsui T; Vasar E
    Psychopharmacology (Berl); 2001 Nov; 158(2):198-204. PubMed ID: 11702094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.